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Abstract 1 
Poly(methyl methacrylate) (PMMA) microfluidic devices have become promising 2 
platforms for a wide range of applications. Here we report a simple method for 3 
immobilising histidine-tagged enzymes suitable for PMMA microfluidic devices. 4 
The reported 1-step-immobilisation is based on the affinity of His-tag/Ni-NTA 5 
interaction and does not require prior amination of PMMA surface, unlike many 6 
existing protocols. We compared it with a 3-step immobilisation protocol involving 7 
amination of PMMA and linking NTA via a glutaraldehyde cross-linker. These 8 
methods were applied to immobilise transketolase (TK) in PMMA microfluidic 9 
devices. Binding efficiency studies showed that approximately 15% of the supplied 10 
TK was bound using the 1-step method and approximately 26% of the enzyme bound 11 
by the 3-step method. However, the TK-catalysed reaction producing L-erythrulose  12 
performed in microfluidic devices showed that specific activity of TK in the device 13 
utilising 1-step immobilisation method was approximately 30% higher than that of 14 
its counterpart. Reusability of the microfluidic device produced via 1-step method 15 
was tested for three cycles of enzymatic reaction and at least 85% of the initial 16 
productivity was maintained. The microfluidic device could be operated for up to 40 17 
hours in a continuous flow and on average 70% of the initial productivity was 18 
maintained. The simplified immobilisation method required fewer chemicals and less 19 
time for preparation of the immobilised microfluidic device compared to the 3-step 20 
method while achieving higher specific enzyme activity. The method represents a 21 
promising approach for the development of immobilised enzymatic microfluidic 22 
devices. Additionally, it also could be applied to immobilisation of other histidine-23 
tagged proteins (e.g. antibodies for immunosorbent assays). 24 
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Introduction 1 
Microfluidic devices have found a wide range of applications in the fields of 2 
biotechnology, chemistry and chemical engineering [1-6]. They offer many 3 
advantages such as large surface to volume ratio in microchannels,  enhanced mass 4 
and heat transfer due to shorter diffusion paths [6], improved spatial and temporal 5 
reaction control [7, 8]. 6 
The use of microfluidic devices has also increased in the context of enzymatic 7 
applications. Several techniques, either with free or immobilised enzymes, that 8 
demonstrate the potential of performing biocatalytic processes in microfluidic 9 
systems have been reported [6,7,9,10]. For free enzymes in solution phase, there are 10 
some bottlenecks restricting their use such as the need of an additional downstream 11 
unit operation to recover and reuse them, and long-term operational stability [7]. In 12 
contrast, use of immobilised enzymes offers advantages such as improved stability 13 
and reusability; without the need for purification of the catalyst from substrates and 14 
product [11-14]. However, immobilisation of enzymes on various surfaces can 15 
sometimes affect biocatalyst performance. 16 
Various materials such as glass [15-17], polystyrene [18], silicon [19,20], 17 
underivatized silica [10,21] and poly(methyl methacrylate) (PMMA) [22], have 18 
already been used to immobilise enzymes in microfluidic devices. Out of these, 19 
PMMA is very favorable for rapid prototyping and is widely used for fabrication of 20 
microfluidic devices, due to its low price, biocompatibility, excellent optical 21 
transparency and attractive mechanical and chemical properties [23]. It has also 22 
potential in the creation of fully disposable microfluidic devices favorable for a wide 23 
range of applications, and ideal for preparing “green microchips” as it decomposes 24 
into reusable monomer at a high temperature [23]. Developing fast and simple 25 
immobilisation methods suitable for PMMA material are of fundamental importance 26 
for the development of immobilised microfluidic systems. 27 
A few approaches have been taken to immobilise enzymes in PMMA flow systems. 28 
Cerqueira et al. covalently immobilised glucose oxidase enzyme in PMMA 29 
microchannels using glutaraldehyde on a preliminarily aminated surface via 30 
 5 
polyethyleneimine [24]. Llopis et al. reported a covalent immobilisation method 1 
attaching active groups directly on PMMA surface of a microfluidic device using N-2 
lithiodiaminoethane, by exposure to UV radiation proceeded by N-(3-3 
dimethylaminopropyl)-N-ethylcarbodiimide coupling of ethylenediamine addition 4 
[25]. Due to the inert nature of PMMA [26], the reported immobilisation methods 5 
were based on PMMA surface functionalisation with amine groups or required 6 
covalent binding of enzymes. The latter prevented reusability of the surface in 7 
contrast to reversible binding methods such as the ones based on His-tag/Ni-NTA 8 
interaction.  9 
His-tag directed immobilisation method applied to PMMA plug flow bioreactor was 10 
reported by Wollenberg et al [27]. The authors used coupling of CYP2C9 enzyme to 11 
UV-activated PMMA via the Ni(II) chelator and histidine tag on the enzyme for 12 
production of drug metabolites [27]. However, this method also contained surface 13 
functionalisation steps making the immobilisation in the PMMA microfluidic device 14 
more laborious and time consuming.  15 
In this work, we report a simplified procedure for histidine-tagged enzyme 16 
immobilisation on the surface of a PMMA microchannel using direct linking of N-17 
(5-Amino-1-carboxypentyl) iminodiacetic acid (AB-NTA) molecules to a modified 18 
PMMA surface without the need for prior amination. Imaging and IR analysis of the 19 
surface were carried out to investigate the proposed simplified immobilisation 20 
method (from here onward called 1-step immobilisation method). We compared the 21 
1-step immobilisation with an established immobilisation protocol (from here 22 
onward called 3-step immobilisation method) that requires an amination step and use 23 
of glutaraldehyde as a cross-linker prior to His-tag/Ni-NTA interaction.  24 
Both techniques were applied to immobilise histidine-tagged transketolase (TK) in a 25 
microfluidic device made out of PMMA. Transketolase enzyme was chosen due to 26 
its wide substrate tolerance and high enantio- and regio-specificity [28], which make 27 
it an attractive biocatalyst for the asymmetric synthesis of chiral metabolites [29-33] 28 
and highly relevant in the pharmaceutical industry. However, the method is 29 
applicable to a large variety of proteins that can be engineered with a His-tag [34]. 30 
The TK-catalysed conversion of hydroxypyruvate (HPA) and glycolaldehyde (GA) 31 
for production of the chiral ketoalcohol L-erythrulose (ERY) was chosen as a model 32 
reaction (Figure 1). We compared specific activities of TK obtained from continuous 33 
 6 
reactions carried out in the microfluidic devices with TK immobilised using 1-step 1 
and 3-step immobilisation methods. Reusability and operational stability studies of 2 
the microfluidic device prepared by the 1-step immobilisation method were studied. 3 
 4 
 5 
 6 
 7 
Figure 1. Reaction scheme of a transketolase (TK) catalysed reaction. Reaction scheme of the 8 
synthesis of L-erythrulose by TK using hydroxypyruvate and glycolaldehyde as substrates. The use of 9 
hydroxypyruvate as carbon donor enables the reaction to go to completion due to the release of carbon 10 
dioxide formed as by-product. The transketolase was immobilised on the surface of a poly(methyl 11 
methacrylate) (PMMA) device.  12 
Materials and Methods  13 
Materials 14 
(5S)-N-(5-Amino-1-carboxypentyl)iminodiacetic acid (AB-NTA) and glutaraldehyde 15 
were purchased from Insight Biotechnology (Wembley, UK). 1,6-Hexanediamine 16 
(HMDA) was obtained from Fisher Scientific (Leicestershire, UK). SDS 4-20% Tris-17 
Glycine Mini-PROTEAN TGXTM Precast Gels and GFP recombinant Aequorea 18 
victoria protein were purchased from BioRad Laboratories Ltd. (Hertfordshire, UK) 19 
and Life Technologies (Paisley, UK), respectively. Poly(methyl methacrylate) 20 
(PMMA) was obtained from RS (Corby, UK) while BSA stock solution and the BCA 21 
protein assay kit were obtained from Thermo Fisher Scientific (UK). All other 22 
reagents were purchased from Sigma-Aldrich (UK). 23 
Microfluidic device fabrication 24 
All components were designed using Adobe Illustrator CS6 software (Adobe 25 
Systems Inc., USA). The device was comprised of two rigid 2 mm PMMA layers. 26 
One of the layers has a channel with additional ridges for increasing the surface area 27 
to volume ratio and the total length is 280 mm (Figure S1).The channels and cutouts 28 
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were fabricated using a CO2 laser marking head (Zing, USA) and the layers were 1 
thermally bonded (2 h, 102.5 °C). Interconnect ports were laser cut from 6 mm thick 2 
PMMA, with two holes tapped with a M3 thread for attachment of the connector to 3 
the device, and an M6 threaded hole to allow standard connection tubing (P-221, 4 
Upchurch Scientific, Oak Harbor, USA) to be attached.  5 
To determine the experimental volume of the microfluidic device, the device with 6 
clean and dry microchannel was connected to a syringe pump (AL 1000-220). Water 7 
was pumped at a fixed flow rate and time that it takes for the water to flow from the 8 
inlet to the outlet was measured. Reactor volume was calculated by multiplying the 9 
given flow rate by the measured time. 10 
Biocatalyst preparation 11 
Transketolase stocks of E. coli BL21gold (DE3) with plasmid pQR791 (His6-TK) 12 
were produced in-house and stored at -80 °C in LB broth containing 50% (v/v) 13 
glycerol. In order to obtain higher enzyme yields, MagicMedia E.coli expression 14 
medium (ThermoFisher Scientific, UK) was used. The complete MagicMedia 15 
medium was prepared using the supplied kit components according to its manual. 16 
The protocol for biocatalyst preparation was similar to that previously described 17 
[35]. Briefly, overnight cultures of E.coli were prepared in flasks containing 10 ml of 18 
LB broth with 150 μg∙mL-1 ampicillin. Cells were sub-cultured using 1% (v/v) 19 
inoculum in 1 L baffled flasks containing 200 mL of the prepared complete 20 
MagicMedia medium with 150 μg∙mL-1 ampicillin and incubated at 37 °C and 250 21 
rpm until the bacterial growth reached stationary phase. Cells were harvested by 22 
centrifugation at 4000 rpm for 20 minutes. The cell pellets were resuspended in 50 23 
mM Tris-HCl pH 7.0 and sonicated on ice (Soniprep 150, MSE Sanyo, Japan). The 24 
suspension was centrifuged at 13,000 rpm and 4 °C for 20 min. The supernatant was 25 
filtered using PVDF syringe filters (Whatman, Maidstone, UK) with a molecular 26 
weight cutoff of 0.2 μm and stored at -20 °C until further use.  27 
 8 
Preparation of poly(methyl methacrylate) microfluidic device with immobilised 1 
His-tagged transketolase 2 
o 3-step immobilisation protocol 3 
Poly(methyl methacrylate) (PMMA) microfluidic device channel was functionalised 4 
and immobilised with His-tagged enzyme according to protocols adapted from Fixe 5 
et al. and Oshige et al. [34, 36]. Briefly, a channel in the PMMA microfluidic device 6 
was flushed and filled with isopropanol (99%) and incubated at 30 °C for 3 hours. 7 
The microfluidic device channel was then rinsed thoroughly with Milli-Q water and 8 
incubated with 10% (v/v) hexamethylene-diamine (HMDA) in 100 mM borate buffer 9 
pH 11.5, for 2 h. The channel was then thoroughly flushed with Milli-Q water for 10 
several channel volumes. Afterwards, the channel was incubated with 1% (v/v) 11 
glutaraldehyde overnight at 37 °C. Another overnight incubation at 37 °C was done 12 
with a 0.05% (w/v) solution of N-(5-amino-1-carboxy-pentyl) iminodiacetic acid 13 
(AB-NTA) in 0.1 M HEPES buffer, pH 8.0. Then, the channel was flushed with 14 
Milli-Q water using syringe pump AL 1000-220 (World Precision Instruments, 15 
USA) at flow rates of 20 μl∙min-1. Finally, a solution of 0.5 M NiCl2 was pumped 16 
through the microchannel at a flow rate of 10 μl∙min-1 for 1 hour followed by a Milli-17 
Q wash.  18 
o 1-step immobilisation protocol 19 
1-step immobilisation protocol was adapted from the 3-step immobilisation by direct 20 
conjugation of AB-NTA molecules to available methyl ester bonds on PMMA 21 
surface. For this purpose, the channel was filled with isopropanol (99%) and 22 
incubated at 30°C for 3 hours. After rinsing with Milli-Q water, the channel was 23 
incubated overnight with 0.05% (w/v) AB-NTA in 0.1 M HEPES buffer, pH 8.0. 24 
Analogously to the 3-step immobilisation, the channel was rinsed with Milli-Q water 25 
and then a 0.5 M NiCl2 solution was pumped through the microchannel at a flow rate 26 
of 10 μl∙min-1 for 1 hour. The channel was washed with Milli-Q before TK 27 
immobilisation.  28 
Transketolase immobilisation and elution 29 
Cell lysates containing TK ranging from 20% to 28% (w/w) were loaded at a protein 30 
concentration of 14.8±2.6 mg∙ml-1 and 14.3±3.1 mg∙ml-1 for the 1-step and 3-step 31 
 9 
immobilised microfluidic devices, respectively. The lysates were pumped into the 1 
microchannels using a syringe pump AL 1000-220 (World Precision Instruments, 2 
USA) at a flow rate of 5 μl∙min-1 at 4 °C for several channel volumes. After 1 h a 3 
solution of 50 mM Tris-HCL, pH 7.5 was pumped through the microchannels at 20 4 
μl∙min-1 to remove non-specifically bound enzyme. Samples were collected 5 
periodically and assayed for protein content. After operational stability studies, the 6 
bound enzyme was removed by treating the channel with EDTA elution buffer (50 7 
mM EDTA; pH 8.0) at 20 µl∙min-1 for at least 2 channel volumes. Collected samples 8 
were concentrated down to 75 µl volume using Amicon Ultra Centrifugal filters 9 
(30,000 NMWL).  10 
Characterisation of immobilisation surface 11 
For Scanning Electron Microscopy (SEM) imaging studies, three PMMA devices 12 
were fabricated following the procedure as described earlier. One microchannel 13 
surface was used as a control and remained untreated. The second and third 14 
microfluidic device channel surfaces were modified using the 1-step immobilisation 15 
protocol and washed to remove any excess or non-specific binding. After this, the 16 
third microfluidic channel surface was used for TK immobilisation as described 17 
earlier and washed with Milli-Q to remove any non-specifically bound enzyme. The 18 
channel surfaces were dried and sputter-coated by a mix of gold and platinum 19 
nanoparticle layer to allow good conductivity on the surface. SEM imaging of the 20 
pre-treated samples was carried out using JEOL 5610LV system with magnifications 21 
ranging from 100 to 20 000-fold. 22 
Fourier transform infrared (FT-IR) spectra of bare PMMA and the AB-NTA 23 
conjugated PMMA surfaces were recorded on Bruker platinum ATR. Samples were 24 
two microchannel surfaces that were laser cut in 2mm PMMA slabs following the 25 
fabrication procedure described earlier. Bare PMMA surface was cleaned and dried 26 
before measurement. Following 1-step immobilisation procedure on a bare PMMA 27 
surface and after incubation with AB-NTA, the surface was washed with Milli-Q to 28 
remove any non-bound AB-NTA molecules. The surface was dried before FT-IR 29 
spectroscopy.  30 
 10 
Transketolase reactions in microfluidic device 1 
Transketolase reaction in the microfluidic device was carried out at 4 ºC. A cofactor 2 
solution of 4.8 mM thiamine diphosphate (ThDP) and 19.6 mM magnesium 3 
dichloride (MgCl2) in 50mM Tris-HCL, pH 7.0 was pumped through the 4 
microchannel at 10 µl∙min-1 (KDS100, KD Scientific, Holliston, USA) for 30 min. 5 
Afterwards, a substrate mix of 12.5 mM glycolaldehyde (GA) and 12.5 mM 6 
hydroxypyruvate (HPA) in 50mM Tris-HCL pH 7.0 was flown through the reactor at 7 
flow rates ranging from 2.3 to 30 μl∙min-1 (mean residence times of 25 to 1 min, 8 
respectively). Samples generated from each flow rate were collected into Eppendorf 9 
tubes containing 0.1% (v/v) trifluoroacetic acid and analysed by HPLC.  10 
Reusability and operational enzyme stability studies 11 
After each reaction run, the microfluidic device was washed with 50 mM EDTA pH 12 
8.0 at 20 µl∙min-1 for two microchannel volumes at room temperature. Samples were 13 
collected and assayed for protein content. The microfluidic device was stored at -20 14 
°C until further use. For the next cycle of immobilisation, the microfluidic device 15 
was first washed with Milli-Q water at 20 μl∙min-1 and then the surface was 16 
regenerated with NiCl2 as described in 1-step immobilisation method section. 17 
Loading of TK was carried out as mentioned in transketolase immobilisation and 18 
elution section.  19 
Operational stability study was conducted in a microfluidic device with TK 20 
immobilised through 1-step immobilisation. After TK immobilisation and washing 21 
steps, TK reaction was carried out under a constant flow rate of 5 μl∙min-1 for up to 22 
40 hours. Samples were collected at various times into tubes with 0.1% (v/v) 23 
trifluoroacetic acid and analysed for ERY production by HPLC.  24 
Analytics 25 
o  SDS-PAGE and protein concentration determination 26 
SDS-PAGE protein analysis was performed using a Mini-155 Protean II system 27 
(Bio-Rad Laboratories Inc., Hemel Hempstead, UK) with SDS 12% Tris-Glycine 28 
(BioRad, UK) pre-cast gels using 10x Tris/Glycine/SDS electrophoresis buffer 29 
(BioRad, UK). Gels were stained with Instant Blue (Expedeon Ltd., Cambridge, 30 
 11 
UK). Destaining was performed in Milli-Q water overnight and a Gel-Doc-it 1 
bioimaging system (Bioimaging systems, Cambridge) was used to visualize the gels. 2 
Protein concentration was determined in triplicates using the Micro BCA protein 3 
assay kit (Thermo Scientific, UK) according to the manufacturer instructions. 4 
Absorbance measurements at 561 nm were carried out on an ATI Unicam UV/VIS 5 
spectrophotometer (Spectronic, Leeds, UK). Protein concentration was quantified 6 
using a calibration curve with bovine serum albumin as standard. 7 
o TK mass and specific activities of transketolase 8 
TK amount of eluted enzyme was determined by SDS-PAGE densitometry. 9 
Densitometry of samples electrophoresed on a 12% SDS-PAGE gel (Bio-Rad) was 10 
used. To calculate the mass of eluted enzyme in elution studies, imaging and 11 
quantification was done using GE Amersham Imager 600. A range of concentrations 12 
of commercial BSA was run on an SDS-Page gel to obtain a standard curve based on 13 
integrated band density for calibration of the enzyme concentration. BSA 14 
concentration of 0.5 mg∙mL-1 was used as a reference band on all other gels to 15 
account for variation in density obtained from different gels.  16 
For enzyme binding efficiency and consequent specific activity determination studies 17 
previously imaged gels were analysed using ImageQuant TL Version 8.1 to calculate 18 
the TK band density relative to the total band density. Total protein in the samples 19 
was determined using a BCA assay. 20 
Substrate and product quantification of TK-catalysed reactions 21 
L-erythrulose (L-ERY) and hydroxypyruvate (HPA) were quantified with HPLC 22 
(Ultimate 3000, Thermo, UK) using an Aminex HPX-87 column (300 mm x 7.8 mm, 23 
Bio-Rad, UK) at 60 ◦C using an isocratic flow of 0.1% (v/v) aqueous trifluoroacetic 24 
acid at 0.6 mL∙min-1. Compounds were detected at 210 nm. 25 
 26 
 27 
 28 
 29 
 12 
Results and discussion 1 
Immobilisation of transketolase on to poly(methyl methacrylate) surface 2 
Many protocols for immobilising enzymes on to polymeric materials require prior 3 
surface modification, since the material surface does not contain suitable functional 4 
groups in their native form [37]. For example, the protocol for immobilisation of 5 
His-tagged proteins on various polymers developed by Oshige et al. requires surface 6 
amination in order to bind glutaraldehyde that is used as a cross-linker enabling 7 
enzyme binding via Ni-NTA [34].  8 
In this work, a 3-step immobilisation method adapted from Oshige et al. based on 9 
amination of PMMA was investigated first [34]. The protocol included amination of 10 
the PMMA surface by using hexamethylene-diamine (HMDA). Glutaraldehyde was 11 
used as a cross-linker to conjugate amine bonds of N-(5-Amino-1-carboxy-pentyl) 12 
iminodiacetic acid (AB-NTA) to the aminated PMMA surface as shown in Figure 13 
2A. However, application of this method was time-consuming, since it took two 14 
overnight incubations to complete the surface treatment.  15 
To establish a simpler protocol with concomitant reduction of surface modification 16 
steps and the time involved, we developed an alternative method where AB-NTA 17 
binds to available methyl esters of PMMA under basic pH conditions forming amide 18 
bonds as shown in Figure 2B. Conjugating AB-NTA on to the surface of PMMA 19 
eliminates the amination step required in existing protocols for enzyme 20 
immobilisation on PMMA and the need of using glutaraldehyde required in the 3-21 
step immobilisation method. 22 
 13 
 1 
Figure 2. 1-step and 3-step immobilisation chemistries on poly(methyl methacrylate) (PMMA) 2 
surface. (A) 3-step immobilisation chemistry. The first line corresponds to amination chemistry of the 3 
surface. The available methyl esters of PMMA, under basic pH conditions, are reacted with an 4 
electron donor (N) present on the hexamethylene-diamine (HMDA), producing primary amines on the 5 
surface. The second line of the scheme represents the linking step of primary amine bonds formed on 6 
PMMA surface with amine bonds of AB-NTA molecule using the cross-linker glutaraldehyde. (B) 1-7 
step immobilisation chemistry. AB-NTA molecule substitutes the HMDA step corresponding to 3-8 
step immobilisation procedure, and amine bonds of AB-NTA molecule react with the available methyl 9 
esters on the PMMA surface, under basic pH conditions. These 1-step and 3-step immobilisation 10 
procedures produce a functionalised PMMA surface that subsequently is used for immobilising 11 
histidine-tagged enzymes. 12 
Characterisation of PMMA microchannel surfaces using scanning electron 13 
microscopy and infrared spectroscopy 14 
To confirm the presence of AB-NTA and consequent immobilisation of TK using 1-15 
step immobilisation method, modified PMMA surfaces were investigated using 16 
infrared spectroscopy and scanning electron microscopy. Figure 3 shows Fourier 17 
transform infrared (FT-IR) spectra and respective scanning electron microscopy 18 
images of unmodified PMMA channel surface (A), AB-NTA treated channel surface 19 
 14 
(B), and of modified PMMA surface with TK immobilised via 1-step immobilisation 1 
method (without IR spectra) (C, D).  2 
The surface of open microchannel before modification steps showed roughness and 3 
re-settled material particles and small cavities due to the laser cutting 4 
microfabrication process (Figure 3A SEM image). Roughness is very favorable for 5 
our application, as it potentially increases the effective area to be modified. The FT-6 
IR spectrum of unmodified PMMA channel shown in Figure 3A presented a set of 7 
bands that are characteristic of pure PMMA surfaces [38]. 8 
The coupling of AB-NTA to the PMMA surface under basic pH conditions was 9 
confirmed by the FT-IR spectrum (Figure 3B), where the peak at ~3400 cm-1 can be 10 
assigned to the N-H stretching vibrations due to amide bond formation [36]. As can 11 
be noticed in respective SEM image of the channel, the presence of AB-NTA on 12 
inner walls does not lead to significant changes in surface profile (Figure 3B SEM 13 
image).  14 
Figure 3(C) and (D) show the SEM images of surfaces with TK immobilised via the 15 
1-step method on to PMMA microchannel surface. These images presented porous 16 
structure that was distinctly different from the AB-NTA treated surface (B) 17 
suggesting that these were enzyme structures bound on to the surface. We presume 18 
that due to the apparent porous surface of the microchannel, the attached enzyme 19 
formed an uneven layer or multiple layers. 20 
 21 
 22 
 23 
 24 
 15 
 1 
Figure 3. Set of Fourier transform infrared spectroscopy spectra and respective scanning 2 
electron microscopy (SEM) images of (A) bare poly(methyl) methacrylate (PMMA) microchannel 3 
surface; (B) microchannel surface treated with AB-NTA according to 1-step immobilisation method  4 
(C) 1000x and (D) 10,000x magnifications of PMMA channel surface after immobilisation of 5 
transketolase using 1-step immobilisation method. 6 
Enzyme binding efficiency in immobilised microfluidic devices  7 
A microfluidic device fabricated out of poly(methyl methacrylate) with a 8 
microchannel and additional grooves for the enhanced surface area was used. The 9 
 16 
internal surface area of the microfluidic channel was calculated as 1,040 mm2 1 
(Supplementary Materials, Section S1). The calculated volume was 80 μL assuming 2 
sharp edges of the designed grooves inside the microchannel. However, the 3 
experimentally determined volume was only 56 μL. The difference is likely due to 4 
the non-rectangular profiles of the microchannel surface, which can be seen from 5 
Figure S2 and therefore, experimentally determined volume was used in all 6 
calculations in this work. 7 
Immobilisation of TK was carried out using a cell lysate obtained from an E. coli 8 
shake flask culture overexpressing a wild-type TK enzyme. Clarified cell lysates at 9 
concentrations of 14.76 and 14.31 mg∙ml-1 (containing 20% and 28% TK 10 
respectively determined via densitometry) were used for loading into the 11 
microfluidic devices modified by 1-step- or 3-step immobilisation methods, 12 
respectively. The enzyme amount retained in the microchannel was determined by a 13 
mass balance between the amount of enzyme loaded at the inlet and that measured at 14 
the outlet and in the wash fractions. In total, 6 to 7 washing steps were performed 15 
with each collected sample containing a solution of one channel volume with the 16 
outlet tubing volume (112 μL for 1-step and 124 μL for 3-step immobilised 17 
microfluidic devices, respectively). Protein quantification of wash fractions after 18 
enzyme immobilisation is shown in Figures 4A and 4B. Using SDS-PAGE 19 
densitometric analysis, percentages of TK relative to total protein in each lane of 20 
SDS-PAGE gels depicted in the insets of Figures 4A and 4B were determined and 21 
used for calculating TK content in each wash fraction. No protein was detected after 22 
the third wash of the microchannel immobilised with TK via 1-step immobilisation 23 
method (Figure 4A inset), while the 3-step microfluidic device samples showed that 24 
small amounts of protein were still detected up to the fifth wash fraction (Figure 4B 25 
inset). To note, a control study of TK loading into bare non-modified PMMA 26 
microfluidic device showed protein wash outs for the entire 7 washes and no 27 
retention of the enzyme in the channel was observed as expected (Figure S3). Based 28 
on the mass balance, the amount of bound TK in the microchannels was estimated to 29 
be 29±15 μg for 1-step and 75±37 μg for 3-step immobilised TK microfluidic 30 
devices, respectively. The amounts represented an average binding efficiency of 31 
~15% for the 1-step and ~26% for the 3-step methods and suggested that 32 
approximately 6 and 15 times more enzyme was immobilised in the microfluidic 33 
 17 
device, respectively, than the theoretically estimated amount for a microchannel of 1 
such geometry. The theoretical amount was estimated assuming monolayer 2 
immobilisation of TK in the microchannel and microfluidic device surface was found 3 
to accommodate approximately 5 μg of transketolase. Details of calculations are 4 
shown in Supplementary Materials, Section S1. The finding supports our 5 
interpretation of SEM images that the porous structure formed increases the available 6 
area for enzyme binding significantly. It is also in agreement with Miyazaki et al. 7 
[39] who reported 8-10 fold higher enzyme amount relative to monolayer coverage 8 
for a His-tagged L-lactic dehydrogenase enzyme immobilised in a derivatised silica 9 
microchannel. Additionally, elution of TK that was immobilised in the microchannel 10 
using 1-step immobilisation method produced a faint band corresponding to TK 11 
molecular weight (Figure S4). Densitometric analysis of the band showed that 12 
approximately 9 µg of TK was recovered from the elution of the microfluidic device 13 
prepared using the 1-step method, which comprised ~31% of the average amount of 14 
TK calculated from the mass balance. This eluted amount of TK was almost twice 15 
higher than the theoretical value calculated from the geometry of the channel. The 16 
difference between the bound TK calculated from the mass balance and that obtained 17 
from the eluted band is likely due to the difficulty of accurately quantifying such 18 
small amounts of enzyme. 19 
 20 
Figure 4. Quantification of transketolase (TK) protein concentration to determine enzyme 21 
binding efficiency of immobilised microfluidic devices prepared by 1-step and 3-step 22 
immobilisation methods. Protein amounts loaded into the microfluidic device and collected in flow-23 
through (wash) fractions from the microchannels with immobilised TK via (A) 1-step and (B) 3-step 24 
methods. Inset: SDS-PAGE gel of protein samples. Lane M corresponds to SDS marker with the 74 25 
kDa band indicative of the size of the TK monomer (72.5 kDa), Lane S shows the amount of protein 26 
loaded (S=~0.20±0.03 mg TK for 1-step and 0.29±0.06 mg TK for 3-step immobilised microfluidic 27 
 18 
devices), and Lanes 1-7 represent the protein content in collected wash fractions. Final immobilised 1 
amount of TK enzyme in microfluidic devices using 1-step and 3-step methods was calculated to be 2 
29±15 μg and 75±36 μg, respectively. Protein detection was done in triplicates. Error bars represent 3 
standard deviation above the mean (n=3). 4 
Transketolase reactions in continuous modes 5 
In order to compare specific activities of TK in two PMMA microfluidic devices 6 
immobilised through 1-step and 3-step methods, the L-erythrulose production was 7 
investigated. Previously, the transketolase-catalysed reaction has been characterised 8 
in continuous flow microreactors with the enzyme immobilised either on the 9 
microchannel walls or on Ni-NTA agarose beads [10, 21]. By contrast, in this work, 10 
a different immobilisation method suitable for PMMA material was used and the 11 
device was operated at higher flow rates ranging from 2 to ~30 μl∙min-1. 12 
Additionally, to ensure the prolonged stability of the enzyme over extended periods 13 
of time the continuous flow reaction was run at 4 °C instead of room temperature. 14 
This would minimise possible thermal deactivation of the enzyme. 15 
Dependence of enzyme conversion on flow rate shown in Figure 5 yielded similar 16 
profiles for microfluidic devices immobilised with 1-step or 3-step methods. Specific 17 
activities of TK in the two devices were found to be 124±13 and 88±11 nmol∙mg-18 
1∙min-1 for 1-step and 3-step immobilisation, respectively. Data were derived from 19 
the product formation determined as a function of residence time shown in Figure S5 20 
in Supplementary Materials section. For immobilised TK enzyme on Ni-NTA 21 
agarose beads previously Halim et al. [21] reported a specific activity of 8.20 22 
μmol∙mg-1∙min-1, while Matosevic et al. [10] reported a specific enzyme activity of 23 
0.8 μmol∙mg-1∙min-1 for TK immobilised on the walls of a silica capillary. The 24 
reduced specific activity found in this study can be explained by the lower 25 
temperature (4 ºC) used in comparison with previous studies that were carried out at 26 
room temperature. 27 
Additionally, the immobilised TK retained only ~4% of the specific activity of the 28 
free enzyme in solution that was found to be 3.38 µmol∙mg-1∙min-1 (Figure S6). This 29 
is in line with earlier data by Matosevic [40], who reported also 4% of the free 30 
enzyme activity was retained using His-tagged immobilisation. For covalent 31 
attachment via cross-linking with glutarldehyde onto the amino-silanized surface 32 
 19 
Thomsen et al. reported that immobilised β-glycoside hydrolase CelB in 1 
microreactor retained only about 3% of the specific activity of the free enzyme, 2 
while the CelB attached to silanized macroporous glass beads in batch, that 3 
employed the same immobilisation technique, retained 35% of the free enzyme 4 
specific activity [41]. Such large differences between immobilised and free enzyme 5 
specific activities could be caused by mass transfer limitations due to an unfavorable 6 
conformation of the immobilised enzyme and/or multi-layer attachment and possibly 7 
some inactivation of the enzyme in an immobilised form [38].  8 
 9 
Figure 5. Conversion of glycolaldehyde (GA) and hydroxypyruvate (HPA) to L-erythrulose (L-10 
ERY) at 4 °C as a function of flow rate in the poly(methyl methacrylate) (PMMA) microfluidic 11 
devices. Comparison of product formation obtained from microfluidic devices with transketolase 12 
(TK) immobilsed via 1-step and 3-step immobilisation techniques. The specific activity values 13 
derived from this data were 124±13 and 88±11 nmol∙min-1∙mg-1 for 1-step and 3-step immobilisation, 14 
respectively. Error bars represent one standard deviation above the mean (n=2). TK-catalysed 15 
reactions were performed using equimolar concentrations of GA and HPA (12.5 mM) each. 16 
Reusability of immobilised microfluidic device prepared by 1-step method 17 
To test reusability of the 1-step immobilisation layer, the performance of the 18 
microfluidic device was tested over multiple immobilisation-elution-regeneration 19 
cycles. Previously reported immobilised microreactors have shown better retention 20 
of enzyme activity than using enzymes in free solutions. For instance, Thomsen et al. 21 
demonstrated consistent productivity of a β-glycoside hydrolase CelB-immobilised 22 
microreactor over 5 days [38]. Matosevic et al. showed successful reusability of a 23 
 20 
silica-based immobilised microreactor over 5 cycles [10]. In this work, the suitability 1 
of 1-step immobilisation protocol for multiple usages over longer periods of time 2 
was investigated. The reusability of the microfluidic device with TK immobilised via 3 
1-step method was studied by using the same microchannel after eluting the enzyme 4 
and reusing the microreactor in three successive runs each with a fresh enzyme. High 5 
productivity levels close to 100% were maintained over 3 cycles operated at a flow 6 
rate of 10 μl∙min-1, although a reduction to 85% was observed in the second reuse 7 
(Figure S7A). It can be concluded the immobilisation surface was stable and activity 8 
of TK was maintained for at least 21 days.  9 
In addition, the operational stability of the TK immobilised microfluidic device via 10 
1-step immobilisation method was investigated under continuous flow over 40 hours 11 
at a flow rate of 5 μl∙min-1. Samples were taken after 1, 14 and 39 hours to measure 12 
the conversion of HPA and GA to ERY product. The productivity of the TK 13 
immobilised in the device decreased to around 65% after 14 h but on average stayed 14 
around 70% for the duration of the study (Figure S7B). The results are similar to 15 
previously obtained values of operational stability of TK immobilised in a packed-16 
bed reactor, where productivity dropped to 76% after 48 h of reaction time [19]. 17 
However, it is worth noting that flow rates used in this study were 5 times higher 18 
than the flow rates used in the reported study (1 μl∙min-1), which may explain the 19 
slight difference in productivities of the immobilised TK.  20 
Conclusions 21 
In this work, 1-step immobilisation of a His-tagged enzyme was investigated as a fast 22 
and simple alternative to existing methods for immobilising enzymes in PMMA 23 
microfluidic devices. The  1-step method was compared to the more common 3-step 24 
immobilisation of histidine-tagged enzymes in PMMA microchannels. We assessed 25 
the chemistries of the two immobilisation techniques and corresponding surface 26 
preparation steps, their enzyme binding efficiencies in microfluidic devices as well 27 
as the specific activities of the immobilised enzyme and conversion yields (Table 1). 28 
The 1-step immobilisation method holds potential advantages over other protocols. 29 
One of the advantages of the 1-step method is the much shorter preparation time. 30 
 21 
Additionally, the number of chemicals required for 1-step immobilisation is 1 
significantly less, since this method does not require a separate surface amination of 2 
PMMA, unlike the 3-step immobilisation protocol. As a result, the immobilisation 3 
cost may potentially be reduced. Furthermore, the presented method requires fewer 4 
wash steps. The simplified 1-step protocol yielded approximately 10% lower enzyme 5 
binding efficiency than the 3-step immobilisation method, however, produced similar 6 
L-erythrulose conversions as a function of flow rate due to higher specific enzyme 7 
activity. The 1-step method presents a viable approach for the development of 8 
enzymatic microfluidic devices and could potentially be applied to combine enzyme 9 
purification with immobilisation of His-tagged proteins from crude cell extracts.  10 
Additionally, it also could be applied to immobilisation of other histidine-tagged 11 
proteins  (e.g. antibodies for immunosorbent assays). 12 
  13 
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Table 1. Comparison of key characteristics of the 1-step and 3-step immobilisation of His-tagged 1 
transketolase in poly(methyl methacrylate) PMMA microfluidic devices. 2 
 3 
 
Characteristic 
 
1-step immobilisation 
 
3-step immobilisation 
Preparation time 1 day 2-3 days 
Number of chemicals 
required 
3 7 
Binding efficiency, (%) ~15 ~26 
Specific activity, 
(nmol∙mg-1∙min-1) 
124±13 88±11 
 4 
 5 
 6 
 7 
 8 
 9 
 10 
 11 
 12 
 13 
 14 
 15 
 16 
 17 
 18 
 19 
 20 
 21 
 22 
 23 
 24 
 25 
 26 
 27 
 28 
 27 
Figure Captions 1 
Figure 1. Reaction scheme of a transketolase (TK) catalysed reaction. Reaction 2 
scheme of the synthesis of L-erythrulose by TK using hydroxypyruvate and 3 
glycolaldehyde as substrates. The use of hydroxypyruvate as carbon donor enables 4 
the reaction to go to completion due to the release of carbon dioxide formed as by-5 
product. The transketolase was immobilised on the surface of a poly(methyl 6 
methacrylate) (PMMA) device.  7 
 8 
Figure 2. 1-step and 3-step immobilisation chemistries on poly(methyl 9 
methacrylate) (PMMA) surface. (A) 3-step immobilisation chemistry. The first line 10 
corresponds to amination chemistry of the surface. The available methyl esters of 11 
PMMA, under basic pH conditions, are reacted with an electron donor (N) present on 12 
the hexamethylene-diamine (HMDA), producing primary amines on the surface. The 13 
second line of the scheme represents the linking step of primary amine bonds formed 14 
on PMMA surface with amine bonds of AB-NTA molecule using the cross-linker 15 
glutaraldehyde. (B) 1-step immobilisation chemistry. AB-NTA molecule substitutes 16 
the HMDA step corresponding to 3-step immobilisation procedure, and amine bonds 17 
of AB-NTA molecule react with the available methyl esters on the PMMA surface, 18 
under basic pH conditions. These 1-step and 3-step immobilisation procedures 19 
produce a functionalised PMMA surface that subsequently is used for immobilising 20 
histidine-tagged enzymes. 21 
 22 
Figure 3. Set of Fourier transform infrared spectroscopy spectra and respective 23 
scanning electron microscopy (SEM) images of (A) bare poly(methyl) 24 
methacrylate (PMMA) microchannel surface; (B) microchannel surface treated with 25 
AB-NTA according to 1-step immobilisation method  (C) 1000x and (D) 10,000x 26 
magnifications of PMMA channel surface after immobilisation of transketolase using 27 
1-step immobilisation method. 28 
 29 
 28 
Figure 4. Quantification of transketolase (TK) protein concentration to 1 
determine enzyme binding efficiency of immobilised microfluidic devices 2 
prepared by 1-step and 3-step immobilisation methods. Protein amounts loaded 3 
into the microfluidic device and collected in flow-through (wash) fractions from the 4 
microchannels with immobilised TK via (A) 1-step and (B) 3-step methods. Inset: 5 
SDS-PAGE gel of protein samples. Lane M corresponds to SDS marker with the 74 6 
kDa band indicative of the size of the TK monomer (72.5 kDa), Lane S shows the 7 
amount of protein loaded (S=~0.20±0.03 mg TK for 1-step and 0.29±0.06 mg TK for 8 
3-step immobilised microfluidic devices), and Lanes 1-7 represent the protein 9 
content in collected wash fractions. Final immobilised amount of TK enzyme in 10 
microfluidic devices using 1-step and 3-step methods was calculated to be 29±15 μg 11 
and 75±36 μg, respectively. Protein detection was done in triplicates. Error bars 12 
represent standard deviation above the mean (n=3). 13 
 14 
Figure 5. Conversion of glycolaldehyde (GA) and hydroxypyruvate (HPA) to L-15 
erythrulose (L-ERY) at 4 °C as a function of flow rate in the poly(methyl 16 
methacrylate) (PMMA) microfluidic devices. Comparison of product formation 17 
obtained from microfluidic devices with transketolase (TK) immobilsed via 1-step 18 
and 3-step immobilisation techniques. The specific activity values derived from this 19 
data were 124±13 and 88±11 nmol∙min-1∙mg-1 for 1-step and 3-step immobilisation, 20 
respectively. Error bars represent one standard deviation above the mean (n=2). TK-21 
catalysed reactions were performed using equimolar concentrations of GA and HPA 22 
(12.5 mM) each. 23 
 24 
 25 
